tak 779 has been researched along with Reperfusion Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Kaimori, J; Kakuta, Y; Matsunami, K; Miyagawa, S; Nonomura, N; Okumi, M; Otsuka, H; Takahara, S; Tsutahara, K; Yazawa, K | 1 |
Akahori, T; Kanehiro, H; Kashizuka, H; Nakajima, Y; Nomi, T; Sho, M | 1 |
2 other study(ies) available for tak 779 and Reperfusion Injury
Article | Year |
---|---|
The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
Topics: Amides; Animals; Base Sequence; CCR5 Receptor Antagonists; Ischemia; Kidney; Male; Natural Killer T-Cells; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, CCR5; Receptors, CXCR3; Reperfusion Injury; RNA, Messenger; T-Lymphocytes | 2012 |
A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury.
Topics: Amides; Animals; CCR5 Receptor Antagonists; DNA Primers; Intestines; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR3; Reperfusion Injury; Survival Analysis | 2006 |